​

HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCA Stock Forecast

HCA Healthcare (HCA) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $455.19, with a high of $579.00 and a low of $369.00. This represents a 10.12% increase from the last price of $413.36.

$250 $320 $390 $460 $530 $600 High: $579 Avg: $455.19 Low: $369 Last Closed Price: $413.36

HCA Stock Rating

HCA Healthcare stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 29 Buy (63.04%), 15 Hold (32.61%), 2 Sell (4.35%), and 0 Strong Sell (0.00%).

Buy
Total 46 0 2 15 29 Strong Sell Sell Hold Buy Strong Buy

HCA Price Target Upside V Benchmarks

TypeNameUpside
StockHCA Healthcare10.12%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks12.31%

Price Target Trends

1M3M12M
# Anlaysts131859
Avg Price Target$438.77$445.00$487.51
Last Closing Price$413.36$413.36$413.36
Upside/Downside6.15%7.65%17.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26113101-25
Jul, 2621391-25
Jun, 2621391-25
May, 2621391-25
Apr, 2621391-25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026Goldman Sachs$485.00$389.6224.48%17.33%
Jul 27, 2026UBS$579.00$390.7048.20%40.07%
Jul 27, 2026Deutsche Bank$476.00$387.4122.87%15.15%
Jul 27, 2026Morgan Stanley$380.00$388.48-2.18%-8.07%
Jul 27, 2026Michael WiederhornOppenheimer$485.00$388.9324.70%17.33%
Jul 27, 2026Robert W. Baird$393.00$382.192.83%-4.93%
Jul 27, 2026Barclays$387.00$382.191.26%-6.38%
Jul 27, 2026KeyBanc$435.00$382.1913.82%5.24%
Jul 20, 2026Stephen BaxterWells Fargo$369.00$371.18-0.59%-10.73%
Jul 16, 2026Barclays$402.00$378.856.11%-2.75%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 27, 2026UBSBuyBuyhold
Jul 27, 2026OppenheimerOutperformOutperformhold
Jul 15, 2026BernsteinMarket PerformMarket Performhold
Jul 08, 2026BarclaysOverweightNegativedowngrade
Jul 01, 2026Cantor FitzgeraldOverweightOverweighthold
Jun 22, 2026Cowen & Co.BuyBuyhold
Jun 04, 2026BernsteinMarket PerformMarket Performhold
Apr 24, 2026JefferiesBuyBuyhold
Mar 10, 2026Cowen & Co.BuyBuyhold
Mar 04, 2026Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

$15 $19 $23 $27 $31 $35 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$21.51$19.44$19.24$22.27$28.62--
Avg Forecast$17.85$17.01$18.20$21.94$24.84$27.96$31.30
High Forecast$18.16$17.35$18.50$22.15$25.34$29.09$32.50
Low Forecast$17.65$16.82$18.04$21.82$24.06$27.03$30.19
Surprise %20.50%14.29%5.71%1.50%15.22%--

Revenue Forecast

$55B $61B $67B $73B $79B $85B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$58.75B$60.23B$64.97B$70.60B$75.60B--
Avg Forecast$59.02B$60.35B$64.15B$70.57B$74.57B$78.43B$82.55B
High Forecast$59.82B$61.26B$64.42B$70.75B$75.20B$79.95B$82.68B
Low Forecast$58.53B$59.82B$63.95B$70.43B$73.83B$77.42B$82.43B
Surprise %-0.46%-0.19%1.27%0.05%1.39%--

Net Income Forecast

$4B $5B $6B $7B $8B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$6.96B$5.64B$5.24B$5.76B$6.78B--
Avg Forecast$5.84B$6.56B$5.24B$5.76B$6.47B$7.35B$8.21B
High Forecast$7.01B$7.87B$6.29B$5.80B$6.63B$7.61B$8.51B
Low Forecast$4.68B$5.25B$4.19B$5.71B$6.30B$7.08B$7.90B
Surprise %19.01%-14.00%--4.93%--

HCA Forecast FAQ

Is HCA Healthcare stock a buy?

HCA Healthcare stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 29 Buy, 15 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that HCA Healthcare is a favorable investment for most analysts.

What is HCA Healthcare's price target?

HCA Healthcare's price target, set by 46 Wall Street analysts, averages $455.19 over the next 12 months. The price target range spans from $369 at the low end to $579 at the high end, suggesting a potential 10.12% change from the previous closing price of $413.36.

How does HCA Healthcare stock forecast compare to its benchmarks?

HCA Healthcare's stock forecast shows a 10.12% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (12.31%).

What is the breakdown of analyst ratings for HCA Healthcare over the past three months?

  • August 2026: 4.00% Strong Buy, 52.00% Buy, 40.00% Hold, 4.00% Sell, 0% Strong Sell.
  • July 2026: 8.00% Strong Buy, 52.00% Buy, 36.00% Hold, 4.00% Sell, 0% Strong Sell.
  • June 2026: 8.00% Strong Buy, 52.00% Buy, 36.00% Hold, 4.00% Sell, 0% Strong Sell.

What is HCA Healthcare’s EPS forecast?

HCA Healthcare's average annual EPS forecast for its fiscal year ending in December 2026 is $27.96, marking a -2.31% decrease from the reported $28.62 in 2025. Estimates for the following years are.

What is HCA Healthcare’s revenue forecast?

HCA Healthcare's average annual revenue forecast for its fiscal year ending in December 2026 is $78.43B, reflecting a 3.75% increase from the reported $75.6B in 2025. The forecast for.

What is HCA Healthcare’s net income forecast?

HCA Healthcare's net income forecast for the fiscal year ending in December 2026 stands at $7.35B, representing an 8.29% increase from the reported $6.78B in 2025. Projections indicate .